Abbott Touts $4 Billion in Drug Sales as It Pitches Spinoff BusinessWeek Daclizumab, the multiple sclerosis treatment, should be on sale by 2015, as will compounds being tested for hepatitis C, the company said. At the same time, the new drug business will seek approval to use Humira in six more disorders, he said. ... |
